These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3038802)

  • 1. Enhancement of radiation effects by alpha interferon in the treatment of small cell carcinoma of the lung.
    Holsti LR; Mattson K; Niiranen A; Standertskiöld-Nordenstam CG; Stenman S; Sovijärvi A; Cantell K
    Int J Radiat Oncol Biol Phys; 1987 Aug; 13(8):1161-6. PubMed ID: 3038802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human leukocyte interferon as part of a combined treatment for previously untreated small cell lung cancer.
    Mattson K; Holsti LR; Niiranen A; Kivisaari L; Iivanainen M; Sovijärvi A; Cantell K
    J Biol Response Mod; 1985 Feb; 4(1):8-17. PubMed ID: 2984340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour response and radiation-induced lung injury in patients with recurrent small cell lung cancer treated with radiotherapy and concomitant interferon-alpha.
    Halme M; Hallman M; Ruotsalainen T; Piilonen A; Taskinen E; Pekonen M; Maasilta P; Mattson K
    Lung Cancer; 1999 Jan; 23(1):39-52. PubMed ID: 10100145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique.
    Mornex F; Trillet V; Chauvin F; Ardiet JM; Schmitt T; Romestaing P; Carrie C; Mahe M; Mornex JF; Fournel P
    Int J Radiat Oncol Biol Phys; 1990 Jul; 19(1):23-30. PubMed ID: 2166018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
    Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer.
    Rosen II; Fischer TA; Antolak JA; Starkschall G; Travis EL; Tucker SL; Hogstrom KR; Cox JD; Komaki R
    Radiology; 2001 Dec; 221(3):614-22. PubMed ID: 11719654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer.
    Choi NC; Herndon JE; Rosenman J; Carey RW; Chung CT; Bernard S; Leone L; Seagren S; Green M
    J Clin Oncol; 1998 Nov; 16(11):3528-36. PubMed ID: 9817271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: evidence for inherent interindividual variation.
    Geara FB; Komaki R; Tucker SL; Travis EL; Cox JD
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):279-86. PubMed ID: 9607342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural interferon-alpha alone and in combination with conventional therapies in non-small cell lung cancer. A pilot study.
    Niiranen A; Holsti LR; Cantell K; Mattson K
    Acta Oncol; 1990; 29(7):927-30. PubMed ID: 2175629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interstitial pneumonia developed after combination chemotherapy with (CDDP, VDS, MMC) and radiotherapy].
    Koga K; Minoda S
    Gan No Rinsho; 1990 May; 36(6):733-5. PubMed ID: 2161469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.
    Vokes EE; Haraf DJ; Drinkard LC; Hoffman PC; Ferguson MK; Vogelzang NJ; Watson S; Lane NJ; Golomb HM
    Cancer Chemother Pharmacol; 1995; 35(4):304-12. PubMed ID: 7530173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
    Mah K; Keane TJ; Van Dyk J; Braban LE; Poon PY; Hao Y
    Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):563-74. PubMed ID: 7509329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide.
    Trask CW; Joannides T; Harper PG; Tobias JS; Spiro SG; Geddes DM; Souhami RL; Beverly PC
    Cancer; 1985 Jan; 55(1):57-60. PubMed ID: 2981141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent cisplatin, prolonged oral etoposide, and vincristine plus chest and brain irradiation for limited small cell lung cancer: a phase II study of the Southwest Oncology Group (SWOG-9229).
    Thomas CR; Giroux DJ; Stelzer KJ; Craig JB; Laufman LR; Taylor SA; Goodwin JW; Crowley JJ; Livingston RB
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1039-47. PubMed ID: 9539558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
    Roach M; Gandara DR; Yuo HS; Swift PS; Kroll S; Shrieve DC; Wara WM; Margolis L; Phillips TL
    J Clin Oncol; 1995 Oct; 13(10):2606-12. PubMed ID: 7595714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
    Müller G; Kiricuta IC; Stiess J; Bohndorf W
    Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of alternating versus sequential radiotherapy/chemotherapy in limited-disease patients with small-cell lung cancer: a European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group Study.
    Gregor A; Drings P; Burghouts J; Postmus PE; Morgan D; Sahmoud T; Kirkpatrick A; Dalesio O; Giaccone G
    J Clin Oncol; 1997 Aug; 15(8):2840-9. PubMed ID: 9256127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodal therapy for limited small-cell lung cancer: a randomized study of induction combination chemotherapy with or without thoracic radiation in complete responders; and with wide-field versus reduced-field radiation in partial responders: a Southwest Oncology Group Study.
    Kies MS; Mira JG; Crowley JJ; Chen TT; Pazdur R; Grozea PN; Rivkin SE; Coltman CA; Ward JH; Livingston RB
    J Clin Oncol; 1987 Apr; 5(4):592-600. PubMed ID: 3031226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.